n24life

[TimAlerts] ADHD - In this trial, MDX did not meet the primary endpoint of demonstrating a statistically significant difference from placebo in the change from baseline of the investigator rating of the Conners’ Adult ADHD Rating Scales (CAARS).

TheR8Guy

[TimAlerts] ADHD - Alcobra Ltd. (ADHD) Announces Phase 3 Trial of MDX in Adults with ADHD Missed Primary Endpoint

jpd

[TimAlerts] ADHD trying to bounce back and run, but needs more volume

Page
of 11